Erratum: Glycogen Synthase Kinase-3 Inhibition Promotes Proliferation and Neuronal Differentiation of Human-Induced Pluripotent Stem Cell-Derived Neural Progenitors by Esfamdoaro F (Stem Cells Dev (2011) 21:17 (3233-3242) DOI: 10.1089/scd.2011.0678);Glycogen synthase kinase-3 inhibition promotes proliferation and neuronal differentiation of human-induced pluripotent stem cell-derived neural progenitors

Stem Cells and Development

Volumn 21, Issue 17, 2012, Pages 3233-3243

  Esfandiari, Fereshteh ^a,b   Fathi, Ali ^a,b   Gourabi, Hamid ^a   Kiani, Sahar ^a   Nemati, Shiva ^a   Baharvand, Hossein ^a,b  

^a ROYAN INSTITUTE FOR REPRODUCTIVE BIOMEDICINE   (Iran)

^b UNIVERSITY OF SCIENCE AND CULTURE   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CYCLIN D1; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; GLYCOGEN SYNTHASE KINASE 3; MYC PROTEIN; NOTCH RECEPTOR; TRANSCRIPTION FACTOR HES 1; TRANSCRIPTION FACTOR HES 5;

ARTICLE; CELL ADHESION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME INHIBITION; GENE TARGETING; HUMAN; HUMAN CELL; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STABILITY; SIGNAL TRANSDUCTION; STEM CELL EXPANSION;

EID: 84869042086     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2011.0678.correx     Document Type: Erratum

References (66)

1. Takahashi K, K Tanabe, M Ohnuki, M Narita, T Ichisaka, K Tomoda and S Yamanaka. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861-872. (Pubitemid 350138099)
2. Yu J, MA Vodyanik, K Smuga-Otto, J Antosiewicz-Bourget, JL Frane, S Tian, J Nie, GA Jonsdottir, V Ruotti, et al. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917-1920.
3. Nemati S, M Hatami, S Kiani, K Hemmesi, H Gourabi, N Masoudi, S Alaei and H Baharvand. (2011). Long-term selfrenewable feeder-free human induced pluripotent stem cellderived neural progenitors. Stem Cells Dev 20:503-514.
4. Tsuji O, K Miura, K Fujiyoshi, S Momoshima, M Nakamura and H Okano. (2011). Cell therapy for spinal cord injury by neural stem/progenitor cells derived from iPS/ES cells. Neurotherapeutics 8:668-676.
5. Jaeger I, C Arber, JR Risner-Janiczek, J Kuechler, D Pritzsche, IC Chen, T Naveenan, MA Ungless and M Li. (2011). Temporally controlled modulation of FGF/ERK signaling directs midbrain dopaminergic neural progenitor fate in mouse and human pluripotent stem cells. Development 138:4363-4374.
6. Sanchez-Danes A, A Consiglio, Y Richaud, I Rodriguez-Piza, B Dehay, M Edel, J Bove, M Memo, M Vila, A Raya and JC Izpisua Belmonte. (2011). Efficient generation of A9 midbrain dopaminergic neurons by lentiviral delivery of lmx1a in human embryonic stem cells and iPS cells. Hum Gene Ther 23:56-69.
7. Ruff CA and MG Fehlings. (2010). Neural stem cells in regenerative medicine: bridging the gap. Panminerva Med 52:125-147.
8. Misztal K, MB Wisniewska, M Ambrozkiewicz, A Nagalski and J Kuznicki. (2011). WNT protein-independent constitutive nuclear localization of {beta}-catenin protein and its low degradation rate in thalamic neurons. J Biol Chem 286: 31781-31788.
9. Mao Y, X Ge, CL Frank, JM Madison, AN Koehler, MK Doud, C Tassa, EM Berry, T Soda, et al. (2009). Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3beta/beta-catenin signaling. Cell 136:1017-1031.
10. Prajerova I, P Honsa, A Chvatal and M Anderova. (2010). Distinct effects of sonic hedgehog and Wnt-7a on differentiation of neonatal neural stem/progenitor cells in vitro. Neuroscience 171:693-711.
11. Kalani MY, SH Cheshier, BJ Cord, SR Bababeygy, H Vogel, IL Weissman, TD Palmer and R Nusse. (2008). Wnt-mediated self-renewal of neural stem/progenitor cells. Proc Natl Acad Sci U S A 105:16970-16975.
12. Yoshinaga Y, T Kagawa, T Shimizu, T Inoue, S Takada, J Kuratsu and T Taga. (2010). Wnt3a promotes hippocampal neurogenesis by shortening cell cycle duration of neural progenitor cells. Cell Mol Neurobiol 30:1049-1058.
13. Davidson KC, P Jamshidi, R Daly, MT Hearn, MF Pera and M Dottori. (2007). Wnt3a regulates survival, expansion, and maintenance of neural progenitors derived from human embryonic stem cells. Mol Cell Neurosci 36:408-415. (Pubitemid 47633203)
14. Shimizu T, T Kagawa, T Inoue, A Nonaka, S Takada, H Aburatani and T Taga. (2008). Stabilized beta-catenin functions through TCF/LEF proteins and the Notch/RBPJkappa complex to promote proliferation and suppress differentiation of neural precursor cells. Mol Cell Biol 28: 7427-7441.
15. Chenn A and CA Walsh. (2002). Regulation of cerebral cortical size by control of cell cycle exit in neural precursors. Science 297:365-369. (Pubitemid 34790759)
16. Viti J, A Gulacsi and L Lillien. (2003). Wnt regulation of progenitor maturation in the cortex depends on Shh or fibroblast growth factor 2. J Neurosci 23:5919-5927. (Pubitemid 36807871)
17. Schmole AC, A Brennfuhrer, G Karapetyan, R Jaster, A Pews-Davtyan, R Hubner, S Ortinau, M Beller, A Rolfs and MJ Frech. (2010). Novel indolylmaleimide acts as GSK-3beta inhibitor in human neural progenitor cells. Bioorg Med Chem 18:6785-6795.
18. Hubner R, AC Schmole, A Liedmann, MJ Frech, A Rolfs and J Luo. (2010). Differentiation of human neural progenitor cells regulated by Wnt-3a. Biochem Biophys Res Commun 400:358-362.
19. Feng B, JH Ng, JC Heng and HH Ng. (2009). Molecules that promote or enhance reprogramming of somatic cells to induced pluripotent stem cells. Cell Stem Cell 4:301-312.
20. Yuan X, W Li and S Ding. (2011). Small molecules in cellular reprogramming and differentiation. Prog Drug Res 67: 253-266.
21. Li W and S Ding. (2010). Small molecules that modulate embryonic stem cell fate and somatic cell reprogramming. Trends Pharmacol Sci 31:36-45.
22. Efe JA and S Ding. (2011). The evolving biology of small molecules: controlling cell fate and identity. Philos Trans R Soc Lond B Biol Sci 366:2208-2221.
23. Lyssiotis CA, LL Lairson, AE Boitano, H Wurdak, S Zhu and PG Schultz. (2011). Chemical control of stem cell fate and developmental potential. Angew Chem Int Ed Engl 50: 200-242.
24. Zhou J, P Su, D Li, S Tsang, E Duan and F Wang. (2010). High-efficiency induction of neural conversion in human ESCs and human induced pluripotent stem cells with a single chemical inhibitor of transforming growth factor beta superfamily receptors. Stem Cells 28:1741-1750.
25. Lange C, E Mix, J Frahm, A Glass, J Muller, O Schmitt, AC Schmole, K Klemm, S Ortinau, et al. (2011). Small molecule GSK-3 inhibitors increase neurogenesis of human neural progenitor cells. Neurosci Lett 488:36-40.
26. Totonchi M, A Taei, A Seifinejad, M Tabebordbar, H Rassouli, A Farrokhi, H Gourabi, N Aghdami, G Hosseini-Salekdeh and H Baharvand. (2010). Feeder-and serum-free establishment and expansion of human induced pluripotent stem cells. Int J Dev Biol 54:877-886.
27. Huang SM, YM Mishina, S Liu, A Cheung, F Stegmeier, GA Michaud, O Charlat, E Wiellette, Y Zhang, et al. (2009). Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. Nature 461:614-620.
28. Strosznajder RP, H Jesko, M Banasik and S Tanaka. (2005). Effects of p53 inhibitor on survival and death of cells subjected to oxidative stress. J Physiol Pharmacol 56 Suppl 4:215-221. (Pubitemid 43142783)
29. Livak KJ and TD Schmittgen. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408. (Pubitemid 34164012)
30. Bullwinkel J, B Baron-Luhr, A Ludemann, C Wohlenberg, J Gerdes and T Scholzen. (2006). Ki-67 protein is associated with ribosomal RNA transcription in quiescent and proliferating cells. J Cell Physiol 206:624-635. (Pubitemid 43191037)
31. Foltz DR, MC Santiago, BE Berechid and JS Nye. (2002). Glycogen synthase kinase-3beta modulates notch signaling and stability. Curr Biol 12:1006-1011. (Pubitemid 34703331)
32. Sade H, S Krishna and A Sarin. (2004). The anti-apoptotic effect of Notch-1 requires p56lck-dependent, Akt/PKBmediated signaling in T cells. J Biol Chem 279:2937-2944. (Pubitemid 38114286)
33. Ruel L, M Bourouis, P Heitzler, V Pantesco and P Simpson. (1993). Drosophila shaggy kinase and rat glycogen synthase kinase-3 have conserved activities and act downstream of Notch. Nature 362:557-560. (Pubitemid 23113033)
34. Espinosa L, J Ingles-Esteve, C Aguilera and A Bigas. (2003). Phosphorylation by glycogen synthase kinase-3{beta} downregulates notch activity, a link for notch and wnt pathways. J Biol Chem 278:32227-32235. (Pubitemid 37048415)
35. Cadigan KM and R Nusse. (1997). Wnt meeting 1996. Biochim Biophys Acta 1332:R1-R5. (Pubitemid 27112553)
36. Fonar Y and D Frank. (2011). FAK and WNT signaling: the meeting of two pathways in cancer and development. Anticancer Agents Med Chem 11:600-606.
37. Ma W, RT Yan, W Mao and SZ Wang. (2009). Neurogenin3 promotes early retinal neurogenesis. Mol Cell Neurosci 40:187-198.
38. Ang SL. (2006). Transcriptional control of midbrain dopaminergic neuron development. Development 133:3499-3506.
39. Meijer L, M Flajolet and P Greengard. (2004). Pharmacological inhibitors of glycogen synthase kinase 3. Trends Pharmacol Sci 25:471-480. (Pubitemid 39149703)
40. Hur EM and FQ Zhou. (2010). GSK3 signalling in neural development. Nat Rev Neurosci 11:539-551.
41. Trowbridge JJ, A Xenocostas, RT Moon and M Bhatia. (2006). Glycogen synthase kinase-3 is an in vivo regulator of hematopoietic stem cell repopulation. Nat Med 12:89-98. (Pubitemid 43050082)
42. Ling L, V Nurcombe and SM Cool. (2009). Wnt signaling controls the fate of mesenchymal stem cells. Gene 433:1-7.
43. Kim WY, X Wang, Y Wu, BW Doble, S Patel, JR Woodgett and WD Snider. (2009). GSK-3 is a master regulator of neural progenitor homeostasis. Nat Neurosci 12:1390-1397.
44. Cajanek L, D Ribeiro, I Liste, CL Parish, V Bryja and E Arenas. (2009). Wnt/beta-catenin signaling blockade promotes neuronal induction and dopaminergic differentiation in embryonic stem cells. Stem Cells 27:2917-2927.
45. Hirabayashi Y, Y Itoh, H Tabata, K Nakajima, T Akiyama, N Masuyama and Y Gotoh. (2004). The Wnt/beta-catenin pathway directs neuronal differentiation of cortical neural precursor cells. Development 131:2791-2801. (Pubitemid 38997270)
46. Takashima A. (2009). Drug development targeting the glycogen synthase kinase-3beta (GSK-3beta)-mediated signal transduction pathway: role of GSK-3beta in adult brain. J Pharmacol Sci 109:174-178.
47. Adachi K, Z Mirzadeh, M Sakaguchi, T Yamashita, T Nikolcheva, Y Gotoh, G Peltz, L Gong, T Kawase, et al. (2007). Beta-catenin signaling promotes proliferation of progenitor cells in the adult mouse subventricular zone. Stem Cells 25:2827-2836. (Pubitemid 350127867)
48. Hirsch C, LM Campano, S Wohrle and A Hecht. (2007). Canonical Wnt signaling transiently stimulates proliferation and enhances neurogenesis in neonatal neural progenitor cultures. Exp Cell Res 313:572-587. (Pubitemid 46186307)
49. Maurer MH, JO Bromme, RE Feldmann, Jr., A Jarve, F Sabouri, HF Burgers, DW Schelshorn, C Kruger, A Schneider and W Kuschinsky. (2007). Glycogen synthase kinase 3beta (GSK3beta) regulates differentiation and proliferation in neural stem cells from the rat subventricular zone. J Proteome Res 6:1198-1208. (Pubitemid 46480485)
50. Manceur AP, M Tseng, T Holowacz, I Witterick, R Weksberg, RD McCurdy, JJ Warsh and J Audet. (2011). Inhibition of glycogen synthase kinase-3 enhances the differentiation and reduces the proliferation of adult human olfactory epithelium neural precursors. Exp Cell Res 317:2086-2098.
51. Castelo-Branco G, N Rawal and E Arenas. (2004). GSK-3beta inhibition/beta-catenin stabilization in ventral midbrain precursors increases differentiation into dopamine neurons. J Cell Sci 117:5731-5737. (Pubitemid 40123940)
52. Maretto S, M Cordenonsi, S Dupont, P Braghetta, V Broccoli, AB Hassan, D Volpin, GM Bressan and S Piccolo. (2003). Mapping Wnt/beta-catenin signaling during mouse development and in colorectal tumors. Proc Natl Acad Sci U S A 100:3299-3304. (Pubitemid 36356577)
53. David MD, C Canti and J Herreros. (2010). Wnt-3a and Wnt-3 differently stimulate proliferation and neurogenesis of spinal neural precursors and promote neurite outgrowth by canonical signaling. J Neurosci Res 88:3011-3023.
54. Kim WY, FQ Zhou, J Zhou, Y Yokota, YM Wang, T Yoshimura, K Kaibuchi, JR Woodgett, ES Anton and WD Snider. (2006). Essential roles for GSK-3s and GSK-3-primed substrates in neurotrophin-induced and hippocampal axon growth. Neuron 52:981-996. (Pubitemid 44909402)
55. Kunke D, V Bryja, L Mygland, E Arenas and S Krauss. (2009). Inhibition of canonical Wnt signaling promotes gliogenesis in P0-NSCs. Biochem Biophys Res Commun 386:628-633.
56. Kuwabara T, J Hsieh, A Muotri, G Yeo,MWarashina, DC Lie, L Moore, K Nakashima, M Asashima and FH Gage. (2009). Wnt-mediated activation of NeuroD1 and retro-elements during adult neurogenesis. Nat Neurosci 12:1097-1105.
57. Liu M, SJ Pleasure, AE Collins, JL Noebels, FJ Naya, MJ Tsai and DH Lowenstein. (2000). Loss of BETA2/NeuroD leads to malformation of the dentate gyrus and epilepsy. Proc Natl Acad Sci U S A 97:865-870. (Pubitemid 30070401)
58. Miyata T, T Maeda and JE Lee. (1999). NeuroD is required for differentiation of the granule cells in the cerebellum and hippocampus. Genes Dev 13:1647-1652. (Pubitemid 29325870)
59. Hsieh J, K Nakashima, T Kuwabara, E Mejia and FH Gage. (2004). Histone deacetylase inhibition-mediated neuronal differentiation of multipotent adult neural progenitor cells. Proc Natl Acad Sci U S A 101:16659-16664. (Pubitemid 39557769)
60. Lee J, Y Wu, Y Qi, H Xue, Y Liu, D Scheel, M German, M Qiu, F Guillemot, M Rao and G Gradwohl. (2003). Neurogenin3 participates in gliogenesis in the developing vertebrate spinal cord. Dev Biol 253:84-98. (Pubitemid 36068005)
61. Castelo-Branco G, J Wagner, FJ Rodriguez, J Kele, K Sousa, N Rawal, HA Pasolli, E Fuchs, J Kitajewski and E Arenas. (2003). Differential regulation of midbrain dopaminergic neuron development by Wnt-1, Wnt-3a, and Wnt-5a. Proc Natl Acad Sci U S A 100:12747-12752. (Pubitemid 37339970)
62. Rhee YH, JY Ko, MY Chang, SH Yi, D Kim, CH Kim, JW Shim, AY Jo, BW Kim, et al. (2011). Protein-based human iPS cells efficiently generate functional dopamine neurons and can treat a rat model of Parkinson disease. J Clin Invest 121:2326-2335.
63. Hargus G, O Cooper, M Deleidi, A Levy, K Lee, E Marlow, A Yow, F Soldner, D Hockemeyer, et al. (2010). Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats. Proc Natl Acad Sci U S A 107:15921-15926.
64. Tsuji O, K Miura, Y Okada, K Fujiyoshi, M Mukaino, N Nagoshi, K Kitamura, G Kumagai, M Nishino, et al. (2010). Therapeutic potential of appropriately evaluated safeinduced pluripotent stem cells for spinal cord injury. Proc Natl Acad Sci U S A 107:12704-12709.
65. Zhou L, W Wang, Y Liu, JF de Castro, T Ezashi, BP Telugu, RM Roberts, HJ Kaplan and DC Dean. (2011). Differentiation of induced pluripotent stem cells of swine into rod photoreceptors and their integration into the retina. Stem Cells 29:972-980.
66. Kriks S, JW Shim, J Piao, YM Ganat, DR Wakeman, Z Xie, L Carrillo-Reid, G Auyeung, C Antonacci, et al. (2011). Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease. Nature 480:547-551.